Immunoglobulin G responses to variant forms of Plasmodium vivax merozoite surface protein 9 upon natural infection in Thailand
Open Access
- 5 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 11 (1), 1-12
- https://doi.org/10.1038/s41598-021-82928-4
Abstract
Merozoite surface protein 9 (MSP9) constitutes a ligand complex involved in erythrocyte invasion by malarial merozoites and is a promising vaccine target. Plasmodium vivax MSP9 (PvMSP9) is immunogenic upon natural malaria exposure. To address whether sequence diversity in PvMSP9 among field isolates could affect natural antibody responses, the recombinant proteins representing two variants each for the N- and the C-terminal domains of PvMSP-9 were used as antigens to assess antibody reactivity among 246 P. vivax-infected patients’ sera from Tak and Ubon Ratchathani Provinces in Thailand. Results revealed that the seropositivity rates of IgG antibodies to the N-terminal antigens were higher than those to the C-terminal antigens (87.80% vs. 67.48%). Most seropositive sera were reactive to both variants, suggesting the presence of common epitopes. Variant-specific antibodies to the N- and the C-terminal antigens were detected in 15.85% and 16.70% of serum samples, respectively. These seropositivity rates were not significant difference between provinces. The seropositivity rates, levels and avidity of anti-PvMSP9 antibodies exhibited positive trends towards increasing malaria episodes. The IgG isotype responses to the N- and the C-terminal antigens were mainly IgG1 and IgG3. The profile of IgG responses may have implications for development of PvMSP9-based vaccine.Funding Information
- the 100th Anniversary Chulalongkorn University Fund for doctoral scholarship
- The Thai Government Research Budgets (GRB-APS-12593011 and GBA-600093004, GRB-APS-12593011 and GBA-600093004, GRB-APS-12593011 and GBA-600093004)
- Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University (RA60/012, RA60/012)
This publication has 55 references indexed in Scilit:
- Naturally Acquired Immune Responses to P. vivax Merozoite Surface Protein 3α and Merozoite Surface Protein 9 Are Associated with Reduced Risk of P. vivax Malaria in Young Papua New Guinean ChildrenPLoS Neglected Tropical Diseases, 2013
- Lack of Avidity Maturation of Merozoite Antigen-Specific Antibodies with Increasing Exposure to Plasmodium falciparum amongst Children and Adults Exposed to Endemic Malaria in KenyaPLOS ONE, 2012
- Influence of HLA-DRB1 and HLA-DQB1 Alleles on IgG Antibody Response to the P. vivax MSP-1, MSP-3α and MSP-9 in Individuals from Brazilian Endemic AreaPLOS ONE, 2012
- Plasmodium knowlesiMalaria in Humans and Macaques, ThailandEmerging Infectious Diseases, 2011
- Antibody Responses and Avidity of Naturally Acquired Anti-Plasmodium vivax Duffy Binding Protein (PvDBP) Antibodies in Individuals from an Area with Unstable Malaria TransmissionThe American Journal of Tropical Medicine and Hygiene, 2011
- Promiscuous T-cell epitopes of Plasmodium merozoite surface protein 9 (PvMSP9) induces IFN-γ and IL-4 responses in individuals naturally exposed to malaria in the Brazilian AmazonVaccine, 2010
- Differential Prevalence ofPlasmodiumInfections and CrypticPlasmodium knowlesiMalaria in Humans in ThailandThe Journal of Infectious Diseases, 2009
- Target Antigen, Age, and Duration of Antigen Exposure Independently Regulate Immunoglobulin G Subclass Switching in MalariaInfection and Immunity, 2006
- Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malariaVaccine, 2004
- On the function of repetitive domains in protein antigens of Plasmodium and other eukaryotic parasitesParasitology Today, 1991